CD4 and neoplasm: Higher frequencies of CD4+ and CD8+ T cells were observed in both the center and border zones of the tumors treated with RdB/IL23/p35 when compared with RdB/IL12- or RdB/IL23-treated tumor tissues (Figure 5b and Figure S1).